VIMTA LABS
Back to Cashflow Statement
|
VIMTA LABS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-1.90 Cr | ₹-11 Cr | ₹-17 Cr | ₹-4.57 Cr | ₹-0.67 Cr |
What is the latest Cash Flow from Financing Activities ratio of VIMTA LABS ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-1.90 Cr |
Mar2023 | ₹-11 Cr |
Mar2022 | ₹-17 Cr |
Mar2021 | ₹-4.57 Cr |
Mar2020 | ₹-0.67 Cr |
How is Cash Flow from Financing Activities of VIMTA LABS Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-1.90 Cr | Negative | |
Mar2023 | ₹-11 Cr | Negative | |
Mar2022 | ₹-17 Cr | Negative | |
Mar2021 | ₹-4.57 Cr | Negative | |
Mar2020 | ₹-0.67 Cr | - |
Compare Cash Flow from Financing Activities of peers of VIMTA LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VIMTA LABS | ₹2,003.8 Cr | -2.9% | -12.4% | 76.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,580.0 Cr | 0.6% | -0.4% | 4.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,069.0 Cr | -2.2% | 1.7% | 47.3% | Stock Analytics | |
CIPLA | ₹119,919.0 Cr | -0.2% | -1.4% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹115,310.0 Cr | 2.5% | 4.8% | 12.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,402.0 Cr | -2.6% | -8.1% | -4.9% | Stock Analytics |
VIMTA LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VIMTA LABS | -2.9% |
-12.4% |
76.6% |
SENSEX | -1.4% |
0.7% |
2.4% |
You may also like the below Video Courses